(FXH) First Trust Health Care - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US33734X1431 • Health
FXH: Healthcare, Pharmaceuticals, Biotechnology, Medical, Devices
The First Trust Health Care AlphaDEX Fund, listed on the NYSE ARCA under the ticker symbol FXH, is designed to provide investors with a unique approach to tapping into the health care sector. By investing at least 90% of its net assets in the securities that comprise its underlying index, the fund aims to deliver a portfolio that closely tracks the performance of this specific segment of the market. The index itself is a modified equal-dollar weighted index, which means that the securities within it are selected and weighted in a way that seeks to optimize their potential for generating alpha, or returns that exceed those of a benchmark index.
The AlphaDEX selection methodology is a key component of this fund's strategy, as it uses a rules-based approach to identify and select stocks from the Russell 1000 Index that are likely to outperform their peers in the health care sector. This methodology takes into account a range of fundamental and quantitative factors, including price momentum, revenue growth, and other metrics that can help to identify companies with strong growth potential. By focusing on the health care sector, the fund provides investors with a way to target a specific area of the market that is known for its potential for long-term growth and innovation.
From a structural perspective, the First Trust Health Care AlphaDEX Fund is an exchange-traded fund (ETF) that is domiciled in the United States and has an International Securities Identification Number (ISIN) of US33734X1431. As an ETF, it offers investors the benefits of transparency, liquidity, and flexibility, as its holdings are disclosed daily and it can be traded throughout the day on an exchange. The fund's website, which can be found at http://www.ftportfolios.com/, provides additional information on its investment objectives, strategies, and performance, as well as other details that may be of interest to potential investors.
In terms of its categorization, the First Trust Health Care AlphaDEX Fund falls under the health care category of ETFs, which means that it is designed to provide investors with a way to gain exposure to the health care sector in a single investment. This can be attractive to investors who are looking to diversify their portfolios and tap into the potential growth opportunities that exist within this sector, which includes companies involved in pharmaceuticals, biotechnology, medical devices, and other related areas. By using a rules-based approach to select its holdings, the fund seeks to provide a disciplined and systematic way to invest in the health care sector, which can help to reduce the risks associated with individual stock selection.
Additional Sources for FXH ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FXH ETF Overview
Market Cap in USD | 1,066m |
Category | Health |
TER | 0.62% |
IPO / Inception | 2007-05-08 |
FXH ETF Ratings
Growth 5y | 26.0% |
Fundamental | - |
Dividend | 32.4% |
Rel. Strength Industry | -78.7 |
Analysts | - |
Fair Price Momentum | 100.21 USD |
Fair Price DCF | - |
FXH Dividends
Dividend Yield 12m | 0.39% |
Yield on Cost 5y | 0.51% |
Annual Growth 5y | 24.75% |
Payout Consistency | 37.7% |
FXH Growth Ratios
Growth Correlation 3m | -43% |
Growth Correlation 12m | 50% |
Growth Correlation 5y | 17.6% |
CAGR 5y | 5.44% |
CAGR/Mean DD 5y | 0.46 |
Sharpe Ratio 12m | 0.19 |
Alpha | -17.56 |
Beta | 0.87 |
Volatility | 13.93% |
Current Volume | 46.3k |
Average Volume 20d | 55.2k |
As of January 23, 2025, the stock is trading at USD 109.31 with a total of 46,300 shares traded.
Over the past week, the price has changed by +1.77%, over one month by +3.73%, over three months by +0.24% and over the past year by +5.75%.
Neither. Based on ValueRay Analyses, First Trust Health Care is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 26.02 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FXH as of January 2025 is 100.21. This means that FXH is currently overvalued and has a potential downside of -8.32%.
First Trust Health Care has no consensus analysts rating.
According to ValueRays Forecast Model, FXH First Trust Health Care will be worth about 111 in January 2026. The stock is currently trading at 109.31. This means that the stock has a potential upside of +1.5%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 111 | 1.5% |